Valentina Zanuso - Department of Biomedical Sciences, Humanitas University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

372P Third-line (3L) Single-Agent Chemotherapy (Single-Ctx) Versus Combination Chemotherapy (Combo-Ctx) for Patients (pts) with Advanced Pancreatic Cancer (apc): A Retrospective, Single-Center Study

A. Pirozzi,V. Zanuso, G. Tesini, E. Valenzi,R. Balsano,T. Pressiani,F. Gavazzi, A. Zerbi,S. Bozzarelli, L. Rimassa

Annals of Oncology (2024)

引用0浏览0引用

New Systemic Treatment Options for Advanced Cholangiocarcinoma

Valentina Zanuso, Giulia Tesini,Elena Valenzi,Lorenza Rimassa

Journal of liver cancerno. 2 (2024): 155-170

引用0浏览0WOS引用

Review of Immune Therapy in HCC: Where Are We Now and What is the Future

Valentina Zanuso,Angelo Pirozzi, Giulia Tesini,Lorenza Rimassa

Clinical Liver Diseaseno. 1 (2024)

引用0浏览0WOS引用

Third-line (3L) Single-Agent Chemotherapy (Single-Ctx) Versus Combination Chemotherapy (Combo-Ctx) for Patients (pts) with Advanced Pancreatic Cancer (apc): A Retrospective, Single-Center Study

A. Pirozzi,V. Zanuso, G. Tesini, E. Valenzi,R. Balsano,T. Pressiani,F. Gavazzi,A. Zerbi,S. Bozzarelli,L. Rimassa

ANNALS OF ONCOLOGY (2024): S151-S151

引用0浏览0引用

THU-474-YI Immunotherapy in Cholangiocarcinoma: Understanding the Immune Landscape Reveals Treatment Response

Rita Balsano,Tiziana Pressiani,Giulia Milardi,Silvia Bozzarelli,Valentina Zanuso,Angelo Pirozzi, Giulia Tesini, Ana Lleo,Lorenza Rimassa

Journal of Hepatology (2024)

引用0浏览0引用

THU-464 Amap Score Predicts Progression-Free Survival in Patients Receiving Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma

Mathew Vithayathil, Antonio D’Alessio,Claudia Fulgenzi,Ciro Celsa,Giulia Francesca Manfredi, Naoshi Nishida,Martin Schoenlein,Johann von Felden,Kornelius Schulze,Henning Wege, Anwaar Saeed,Brooke Wietharn,Hannah Hildebrand, Linda Wu,Celina Ang,Thomas U. Marron,Arndt Weinmann,Peter R. Galle,Dominik Bettinger,Chun-Yen Lin,Arndt Vogel,Bernhard Scheiner,Pei-Chang Lee,Yi‐Hsiang Huang,Suneetha Amara, Mahvish Muzaffar,Abdul Rafeh Naqash,Valentina Zanuso,Tiziana Pressiani,Giuseppe Cabibbo,Andrea Dalbeni, Matthias Pinter,Amit Singal,Hong Jae Chon,Alessio Cortellini,Masatoshi Kudo,Lorenza Rimassa, David J. Pinato, Reetika Sharma

Journal of hepatology (2024): S443-S443

引用0浏览0引用

Efficacy of Cisplatin-Gemcitabine-durvalumab in Patients with Advanced Biliary Tract Cancer Experiencing Early Vs Late Disease Relapse after Surgery: a Large Real-Life Worldwide Population

Federica Lo Prinzi,Francesca Salani,Margherita Rimini,Mario Domenico Rizzato,Lorenzo Antonuzzo,Silvia Camera,Tomoyuki Satake, Hanne Vandeputte,Caterina Vivaldi,Tiziana Pressiani,Jessica Lucchetti, Jin Won Kim,Oluseyi Abidoye,Ilario Giovanni Rapposelli,Stefano Tamberi,Fabian Finkelmeier,Guido Giordano,Chiara Pircher, Hong Jae Chon,Chiara Braconi,Alessandro Pastorino,Florian Castet,Emiliano Tamburini,Changhoon Yoo, Alessandro Parisi,Anna Diana,Mario Scartozzi,Gerald W. Prager, Antonio Avallone,Marta Schirripa,Il Hwan Kim,Lukas Perkhofer,Ester Oneda,Monica Verrico,Jorge Adeva,Stephen L. Chan,Gian Paolo Spinelli,Nicola Personeni,Ingrid Garajova,Maria Grazia Rodriquenz,Silvana Leo, Cecilia Melo Alvim, Ricardo Roque,Lorenzo Fornaro,Antonio De Rosa,Daniele Lavacchi,Federico Rossari,Masafumi Ikeda,Jeroen Dekervel,Monica Niger,Rita Balsano,Giuseppe Tonini, Minsu Kang,Tanios Bekaii-Saab,Massimo Giuseppe Viola,Lucrezia Silvestro,Luca Esposito,Alessandra Boccaccino,Vera Himmelsbach,Matteo Landriscina,Selma Ahcene Djaballah,Valentina Zanuso,Gianluca Masi,Sara Lonardi,Lorenza Rimassa,Andrea Casadei-Gardini

ONCOLOGIST (2024)

引用0浏览0WOS引用

371P the Role of Diabetes As Prognostic Factor in Patients (pts) with Pancreatic Cancer (PC): A Retrospective, Single-Center Analysis

E. Valenzi,V. Zanuso, A. Pirozzi, G. Tesini,R. Balsano,T. Pressiani,S. Carrara,T. Comito,C. Bonifacio,M. Nebbia,M. Pagnanelli,C. Ridolfi,G. Capretti,F. Gavazzi,G. Nappo,A. Zerbi,S. Bozzarelli,L. Rimassa

Annals of Oncology (2024): S150-S151

引用0浏览0引用

OS-079-YI Development and Validation of the CABLE Score to Estimate Individual Prognosis of Patients with Hepatocellular Carcinoma Treated with 1L Atezolizumab and Bevacizumab

Simon Johannes Gairing, Philipp Mildenberger,Jennifer Gile, Fabian Artusa,Bernhard Scheiner,Catherine Leyh,Sabine Lieb,Friedrich Sinner,Vincent Jörg,Thorben Fruendt,Vera Himmelsbach,Nada Abedin,Cennet Sahin, Katrin Boettcher, Jasmin Schuhbaur,Simon Labuhn,James Korolewicz,Claudia Fulgenzi, Antonio D'Alessio,Valentina Zanuso,Florian Hucke,Natascha Röhlen,Najib Ben Khaled, Eleonora Ramadori, Lukas Müller,Arndt Weinmann,Roman Kloeckner,Peter R. Galle,Nguyen H. Tran,Sudhakar Venkatesh,Andreas Teufel, Enrico de Toni,Dirk-Thomas Waldschmidt, Jens U. Marquardt,Dominik Bettinger,Markus Peck-Radosavljevic,Andreas Geier,Florian P Reiter,Lorenza Rimassa, David J. Pinato, Christoph Roderburg,Thomas Ettrich, Michael Bitzer,Veit Scheble,Ursula Ehmer,Marie-Luise Berres,Fabian Finkelmeier,Maria Angeles Gonzalez-Carmona,Johann von Felden,Kornelius Schulze,Marino Venerito,Florian van Bömmel,Leonie Jochheim, Matthias Pinter, Raphael Mohr,Sumera I. Ilyas,Irene Schmidtmann,Friedrich Foerster

Journal of Hepatology (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn